Enanta Pharmaceuticals shares decline ahead of September quarterly results
ENTA Enanta Pharmaceuticals Inc
$7.62 -4.51%
View chart & analysis → - 1Enanta Pharmaceuticals shares have fallen 20% since the recent update.
- 2The market expects a loss per share of $0.82 for Enanta Pharmaceuticals in the September quarter.
- 3Enanta Pharmaceuticals is projected to have revenue of $14.4 million for the September quarter.
So what's the key point?
Enanta Pharmaceuticals shares have recently dropped by 20%. Investors are concerned because losses are expected to be larger than what experts predicted.
Source Earnings Whispers · View original ↗
Nothing hidden: past picks and how they did against the S&P 500.